Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-01-29Clinical Trial Update: Special Access for the Use of Voclosporin for Kidney Transplantation
Special Access use of voclosporin for kidney transplantation has been discontinued and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus [Phase 4]
Phase 4 trial comparing tacrolimus with Mycophenolate mofetil versus tacrolimus with sirolimus for living donor kidney transplant patients h…
-
CLINICAL_TRIALS withdrawal · 2024-02-28Clinical Trial Update: Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response [Phase 4]
A Phase 4 clinical trial involving mTOR inhibitors and CMV-specific immune response in kidney transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation [Phase 2, Phase 3]
A phase 2/3 clinical trial comparing efalizumab with cyclosporine as immunosuppression in de novo kidney transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-27Clinical Trial Update: Observational Registry Study of Renal Transplant Patients
Observational registry study of renal transplant patients sponsored by Novartis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-02-24Clinical Trial Update: Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients [Phase 4]
A Phase 4 trial evaluating immediate conversion from tacrolimus to everolimus in stable maintenance renal transplant recipients has been wit…
-
CLINICAL_TRIALS withdrawal · 2016-10-21Clinical Trial Update: Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
This clinical trial evaluating how medications are removed during plasmapheresis in kidney transplant patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients [Phase 2]
This Phase 2 trial evaluating the safety and tolerability of inhaled carbon monoxide in kidney transplant patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-23Clinical Trial Update: The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation [NA]
A Cleveland Clinic-sponsored trial evaluating continuous TAP catheters for postoperative pain control after kidney transplantation was termi…
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients [Phase 4]
A Phase 4 trial comparing everolimus versus sirolimus in combination with calcineurin inhibitors for kidney transplant patients has been wit…
-
CLINICAL_TRIALS withdrawal · 2014-06-09Clinical Trial Update: Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation [Phase 4]
Phase 4 clinical trial evaluating methods to attenuate ischemia-reperfusion injury in living donor kidney transplantation has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2014-01-20Clinical Trial Update: Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation [Phase 3]
A Phase 3 trial evaluating voclosporin in combination with tacrolimus for kidney transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-10Clinical Trial Update: Transversus Abdominis Plane (TAP) Block After Kidney Transplantation [NA]
A clinical trial evaluating transversus abdominis plane (TAP) block after kidney transplantation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-02-22Clinical Trial Update: Alefacept in Kidney Transplant Recipients [NA]
The clinical trial evaluating alefacept in kidney transplant recipients has been withdrawn.
-
EMA withdrawal · 2009-02-13EMA Withdrawn: Zenapax (daclizumab) — Roche Registration Ltd.
EMA has withdrawn Zenapax (daclizumab) from the market in January 2007.
-
CLINICAL_TRIALS withdrawal · 2008-05-30Clinical Trial Update: Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients [Phase 2]
Phase 2 study of a JAK3 inhibitor for preventing acute rejection in kidney transplant recipients has been withdrawn.